Laird Norton Wetherby Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Buy |
|
|||||
|
2024
Q4 | $296K | Sell |
|
|||||
|
2024
Q3 | $329K | Sell |
|
|||||
|
2024
Q2 | $353K | Hold |
|
|||||
|
2024
Q1 | $463K | Sell |
|
|||||
|
2023
Q4 | $421K | Buy |
|
|||||
|
2023
Q3 | $347K | Sell |
|
|||||
|
2023
Q2 | $401K | Buy |
|
|||||
|
2023
Q1 | $384K | Sell |
|
|||||
|
2022
Q4 | $420K | Buy |
|
|||||
|
2022
Q3 | $375K | Sell |
|
|||||
|
2022
Q2 | $417K | Buy |
|
|||||
|
2022
Q1 | $509K | Buy |
|
|||||
|
2021
Q4 | $659K | Sell |
|
|||||
|
2021
Q3 | $799K | Sell |
|
|||||
|
2021
Q2 | $721K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $483K | Buy |
|